Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Dec;8(12):1470-6.
doi: 10.1023/a:1015830013451.

The pharmacokinetics of antipyrine and three of its metabolites in the rabbit: intravenous administration of pure metabolites

Affiliations

The pharmacokinetics of antipyrine and three of its metabolites in the rabbit: intravenous administration of pure metabolites

J V St Peter et al. Pharm Res. 1991 Dec.

Abstract

Antipyrine (AP) is a commonly used probe of oxidative metabolism. Indirect evidence demonstrates formation rate limited disposition of its metabolites. Kinetic studies using antipyrine and its major metabolites 3-hydroxymethylantipyrine (HMA), norantipyrine (NORA), and 4-hydroxyantipyrine (OHA) were completed to investigate the metabolic fate of preformed antipyrine metabolite and to demonstrate directly formation rate-limited metabolite disposition in vivo. Bolus injections of antipyrine and preformed metabolites (40-50 mg/kg) were administered to male, New Zealand white rabbits. Plasma and urine were analyzed using HPLC. These studies demonstrate that HMA, NORA, and OHA are formation rate limited in the rabbit. NORA appears to undergo further extensive oxidative and conjugative metabolism. Unknown additional peaks were detected in urine after NORA dosing but not after HMA or OHA administration. Mass spectroscopy of the unknown HPLC eluents identified potential structures of these NORA metabolites.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br J Clin Pharmacol. 1982 Mar;13(3):379-86 - PubMed
    1. J Clin Pharmacol. 1990 Mar;30(3):267-71 - PubMed
    1. Eur J Clin Pharmacol. 1985;28(6):681-4 - PubMed
    1. Xenobiotica. 1983 Mar;13(3):155-62 - PubMed
    1. Br J Clin Pharmacol. 1984 Nov;18(5):707-15 - PubMed

Publication types

LinkOut - more resources